Literature DB >> 18549203

CrAsH-quantum dot nanohybrids for smart targeting of proteins.

Emilie Genin1, Olivier Carion, Benoit Mahler, Benoit Dubertret, Nathalie Arhel, Pierre Charneau, Eric Doris, Charles Mioskowski.   

Abstract

Smart nanohybrids were prepared by conjugation of CrAsH to hydrosoluble and biocompatible quantum dots (QDs). The resulting probes were shown to bind efficiently and selectively to Cys-tagged proteins. The interaction with the protein was detected by an increase of the fluorescence emission of CrAsH. While the latter faded rapidly under continuous excitation, emission of the QD remained unaffected. The persistent fluorescence of the QD should thus allow extended monitoring of the target protein.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18549203     DOI: 10.1021/ja802987q

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  5 in total

Review 1.  Biocompatible quantum dots for biological applications.

Authors:  Sandra J Rosenthal; Jerry C Chang; Oleg Kovtun; James R McBride; Ian D Tomlinson
Journal:  Chem Biol       Date:  2011-01-28

Review 2.  Probing cellular events, one quantum dot at a time.

Authors:  Fabien Pinaud; Samuel Clarke; Assa Sittner; Maxime Dahan
Journal:  Nat Methods       Date:  2010-03-30       Impact factor: 28.547

3.  Optimizing two-color semiconductor nanocrystal immunoassays in single well microtiter plate formats.

Authors:  Kim E Sapsford; Samantha Spindel; Travis Jennings; Guoliang Tao; Robert C Triulzi; W Russ Algar; Igor L Medintz
Journal:  Sensors (Basel)       Date:  2011-08-11       Impact factor: 3.576

Review 4.  Impacts of quantum dots in molecular detection and bioimaging of cancer.

Authors:  Omid Mashinchian; Mohammad Johari-Ahar; Behnaz Ghaemi; Mohammad Rashidi; Jaleh Barar; Yadollah Omidi
Journal:  Bioimpacts       Date:  2014-09-27

5.  Synthesis of Arylazide- and Diazirine-Containing CrAsH-EDT2 Photoaffinity Probes.

Authors:  Shameem S Syeda; Daren Rice; Derek J Hook; Leslie L Heckert; Gunda I Georg
Journal:  Arch Pharm (Weinheim)       Date:  2016-03-07       Impact factor: 3.751

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.